Product Center
Approved as Taizhou Engineering Research Center
- Categories:Company news
- Author:
- Origin:
- Time of issue:2024-07-03
- Views:
(Summary description)Recently, Taizhou Municipal Development and Reform Commission announced the list of engineering research centers in Taizhou in 2024, and "Taizhou Engineering Research Center for Human Vaccine Technology Innovation" constructed by Ab&B Bio-Tech Co. (hereinafter referred to as "Ab&B Bio") was successfully recognized as a municipal engineering research center.
Approved as Taizhou Engineering Research Center
(Summary description)Recently, Taizhou Municipal Development and Reform Commission announced the list of engineering research centers in Taizhou in 2024, and "Taizhou Engineering Research Center for Human Vaccine Technology Innovation" constructed by Ab&B Bio-Tech Co. (hereinafter referred to as "Ab&B Bio") was successfully recognized as a municipal engineering research center.
- Categories:Company news
- Author:
- Origin:
- Time of issue:2024-07-03 17:05
- Views:
Recently, Taizhou Municipal Development and Reform Commission announced the list of engineering research centers in Taizhou in 2024, and "Taizhou Engineering Research Center for Human Vaccine Technology Innovation" constructed by Ab&B Bio-Tech Co. (hereinafter referred to as "Ab&B Bio") was successfully recognized as a municipal engineering research center.
It is understood that this Taizhou engineering research center is recognized to deeply practice the new development concept and innovation-driven development strategy, around the development of new quality productivity in accordance with local conditions, accelerate the deep integration of the innovation chain, industrial chain, capital chain and talent chain, and promote the high-quality development of the city's strategic emerging industries.
Ab&B Bio will through the continuous construction of Taizhou Human Vaccine Technology Innovation Engineering Research Center, aim at solving the huge unmet demand for innovative human vaccines, combine with the actual situation of the enterprise, further enhance the innovation level of the company's technology platform, continue to strengthen the training of talents and team building, carry out scientific and technological innovation and the key core technology research and development, develop the new-quality productive forces, and continue to promote the original scientific and technological achievements. We will continue to strengthen talent training and team building, carry out scientific and technological innovation and key core technology research, develop new productivity, continuously promote the output of original scientific and technological achievements, and contribute to the high-quality development of the biomedical industry and the protection of people's lives, health and social welfare.
Relevant information
-
Ab&B Bio and Yither Bio have both obtained qualification certification!Recently, Ab&B Bio-Tech Co.,Ltd（Ab&B Bio） and its subsidiary Yither biotech (Shanghai) Co., Ltd (Yither Bio) have been recognized as Jiangsu Province's specialized and innovative small and medium-sized enterprises and national high-tech enterprises, respectively. - The kickoff meeting for clinical research on the immunogenicity and safety of quadrivalent influenza virus subunit vaccine for children with nephrotic syndrome was successfully held 12-25
- Influenza virus subunit vaccine (adjuvant) IND application approved 10-30
- The application for the marketing of trivalent influenza virus subunit vaccine has been accepted! 10-08
- Breaking through bottleneck technology, significant progress has been made in the research and development of new adjuvants 08-26
Have a project？Get a touch!
Caring for life, protecting health, and making global technological innovation vaccines are the mission of Ab&B Bio
Contact
E-mail:info@abbbio.com.cn
Add:No. 32, Xinglin Road, Medical High-tech Zone, Taizhou City
Quick view
Follow us
